About Abzena (LON:ABZA)
Abzena plc is a life sciences company. The Company provides technologies and complementary services to enable the development and manufacture of biopharmaceutical products. It has a global customer base which includes approximately 20 biopharmaceutical companies, as well as large and small biotech companies and academic groups. It offers immunogenicity assessment, which includes EpiScreen, iTope and T Cell Epitope Database (TCED); antibody drug conjugates, which includes ThioBridge linkers; antibody, which includes Composite Human Antibodies and Composite Proteins; optimization of pharmacokinetics, which includes TheraPEG, HiPEG conjugates PEG to poly-histidine motifs and CyPEG, and PolyPEG; cell line development, which includes Composite Human Antibody; process development, Good manufacturing practices (GMP) manufacturing, and small molecules. The Company's Abzena inside includes Composite Human Antibodies and ThioBridge Antibody Drug Conjugates (ADCs).
Industry, Sector and Symbol
Industry Biotechnology & Medical Research
Trailing P/E Ratio-306.25
Forward P/E RatioN/A
Sales & Book Value
Price / SalesN/A
Price / CashN/A
Price / BookN/A
Trailing EPSGBX (0.08)
Return on Equity-36.99%
Return on Assets-30.72%
Abzena (LON:ABZA) Frequently Asked Questions
What is Abzena's stock symbol?
Abzena trades on the London Stock Exchange (LON) under the ticker symbol "ABZA."
Where is Abzena's stock going? Where will Abzena's stock price be in 2018?
3 brokers have issued 1-year price objectives for Abzena's shares. Their predictions range from GBX 42 to GBX 80. On average, they expect Abzena's stock price to reach GBX 64 in the next twelve months. View Analyst Ratings for Abzena.
Who are some of Abzena's key competitors?
Some companies that are related to Abzena include Tissue Regenix Group (TRX), Matinas BioPharma (MTNB), Navidea Biopharmaceuticals (NAVB), NovaBay Pharmaceuticals (NBY), Scancell (SCLP), Can Fite Biopharma (CANF), ReNeuron Group (RENE), Repros Therapeutics (RPRX), Akers Biosciences (AKR), AmpliPhi Biosciences (APHB), Synairgen (SNG), Vernalis (VER), Ixico (IXI), ImmunoCellular Therapeutics (IMUC), Genedrive (GDR), Sorrento Tech (ROKA), Celator Pharmaceuticals (CPXX) and Cyprotex (CRX).
Has Abzena been receiving favorable news coverage?
Headlines about ABZA stock have trended somewhat positive on Friday, according to Accern. The research firm identifies positive and negative news coverage by analyzing more than twenty million news and blog sources in real time. Accern ranks coverage of companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Abzena earned a coverage optimism score of 0.17 on Accern's scale. They also assigned media coverage about the company an impact score of 45.48 out of 100, meaning that recent news coverage is somewhat unlikely to have an impact on the company's share price in the near term.
How do I buy shares of Abzena?
Shares of ABZA and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
What is Abzena's stock price today?
One share of ABZA stock can currently be purchased for approximately GBX 24.50.
How big of a company is Abzena?
Abzena has a market capitalization of £50.91 million.
How can I contact Abzena?
Abzena's mailing address is Babraham Hall, Babraham Research, CAMBRIDGE, CB22 3AT, United Kingdom. The company can be reached via phone at +44-1223-903498.
MarketBeat Community Rating for Abzena (ABZA)MarketBeat's community ratings are surveys of what our community members think about Abzena and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.
Earnings History for Abzena (LON:ABZA)
No earnings announcements for this company have been tracked by MarketBeat.com
Abzena (LON:ABZA) Earnings Estimates
No earnings estimates for this company have been tracked by MarketBeat.com
Dividend History for Abzena (LON:ABZA)
No dividend announcements for this company have been tracked by MarketBeat.com
Insider Trading History for Abzena (LON ABZA)
No insider trades for this company have been tracked by MarketBeat.com
Abzena (LON ABZA) News Headlines
Abzena (LON:ABZA) SEC Filings
This page is loading this company's SEC Filings. Please wait...
Financials are not available for this stock.
Abzena (LON ABZA) Stock Chart for Friday, March, 23, 2018